Mangal Keshav Capital has submitted the revised disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 in withdrawal of the earlier disclosure dated 7th July 2016, wherein the shares sold of iStreet Network on 5th July, 2016 were 125,000 which were erroneously stated as 1,250,000 shares.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1954.60 |
| Dr. Reddys Labs. | 1169.50 |
| Cipla | 1397.10 |
| Lupin | 2396.90 |
| Zydus Lifesciences | 1114.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: